Serum immune-activation potency and response to anti-TNF-&alpha; therapy in Crohn's disease

doi:10.3748/wjg.v16.i46.5845

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3428)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

337

HTML

2603

Figures (1-3)

251

Tables (1-2)

237

Sum=3428

Dec 14, 2010 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 14, 2010; 16(46): 5845-5851
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5845

Full Size Figure Download Figure

Figure 3 Patient serum withdrawn before anti-tumor necrosis factor-α therapy induced forkhead transcription factor 3 specific mRNA expression (relative units) in activated target cells that correlated negatively with erythrocyte sedimentation rate. ESR: Erythrocyte sedimentation rate. r = -0.548, P = 0.034.

Citation: Rintamäki H, Sipponen T, Salo HM, Vaarala O, Kolho KL. Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease. World J Gastroenterol 2010; 16(46): 5845-5851
URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5845.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5845